25 XP   0   0   10

Achilles Therapeutics PLC ADR
Buy, Hold or Sell?

Let's analyse Achilles Therapeutics PLC ADR together

PenkeI guess you are interested in Achilles Therapeutics PLC ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Achilles Therapeutics PLC ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Achilles Therapeutics PLC ADR

I send you an email if I find something interesting about Achilles Therapeutics PLC ADR.

Quick analysis of Achilles Therapeutics PLC ADR (30 sec.)










What can you expect buying and holding a share of Achilles Therapeutics PLC ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.43
Expected worth in 1 year
$-1.84
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-5.27
Return On Investment
-655.8%

For what price can you sell your share?

Current Price per Share
$0.80
Expected price per share
$0.74 - $0.875
How sure are you?
50%

1. Valuation of Achilles Therapeutics PLC ADR (5 min.)




Live pricePrice per Share (EOD)

$0.80

Intrinsic Value Per Share

$-14.62 - $-17.14

Total Value Per Share

$-11.18 - $-13.71

2. Growth of Achilles Therapeutics PLC ADR (5 min.)




Is Achilles Therapeutics PLC ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$142.3m$197m-$54.6m-38.4%

How much money is Achilles Therapeutics PLC ADR making?

Current yearPrevious yearGrowGrow %
Making money-$69.9m-$71.1m$1.2m1.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Achilles Therapeutics PLC ADR (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#310 / 1007

Most Revenue
#912 / 1007

Most Profit
#693 / 1007

Most Efficient
#342 / 1007

What can you expect buying and holding a share of Achilles Therapeutics PLC ADR? (5 min.)

Welcome investor! Achilles Therapeutics PLC ADR's management wants to use your money to grow the business. In return you get a share of Achilles Therapeutics PLC ADR.

What can you expect buying and holding a share of Achilles Therapeutics PLC ADR?

First you should know what it really means to hold a share of Achilles Therapeutics PLC ADR. And how you can make/lose money.

Speculation

The Price per Share of Achilles Therapeutics PLC ADR is $0.8037. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Achilles Therapeutics PLC ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Achilles Therapeutics PLC ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.43. Based on the TTM, the Book Value Change Per Share is $-1.32 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Achilles Therapeutics PLC ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.69-209.7%-1.69-209.7%-1.72-213.4%-1.20-149.6%-1.20-149.6%
Usd Book Value Change Per Share-1.32-163.9%-1.32-163.9%-2.23-277.3%0.6985.4%0.6985.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.32-163.9%-1.32-163.9%-2.23-277.3%0.6985.4%0.6985.4%
Usd Price Per Share0.89-0.89-0.90-1.36-1.36-
Price to Earnings Ratio-0.53--0.53--0.52--0.89--0.89-
Price-to-Total Gains Ratio-0.67--0.67--0.40-0.33-0.33-
Price to Book Ratio0.26-0.26-0.19-0.23-0.23-
Price-to-Total Gains Ratio-0.67--0.67--0.40-0.33-0.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8037
Number of shares1244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.320.69
Usd Total Gains Per Share-1.320.69
Gains per Quarter (1244 shares)-1,639.11853.62
Gains per Year (1244 shares)-6,556.443,414.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6556-6566034143404
20-13113-13122068296818
30-19669-1967801024310232
40-26226-2623401365813646
50-32782-3279001707217060
60-39339-3934602048720474
70-45895-4590202390123888
80-52452-5245802731627302
90-59008-5901403073030716
100-65564-6557003414534130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%

Fundamentals of Achilles Therapeutics PLC ADR

About Achilles Therapeutics PLC ADR

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Fundamental data was last updated by Penke on 2024-05-02 09:11:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Achilles Therapeutics PLC ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Achilles Therapeutics PLC ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--214.6%+214.6%
YOY--281.4%+281.4%
5Y--428.1%+428.1%
10Y--595.4%+595.4%
1.1.2. Return on Assets

Shows how efficient Achilles Therapeutics PLC ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • -43.3% Return on Assets means that Achilles Therapeutics PLC ADR generated $-0.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Achilles Therapeutics PLC ADR:

  • The MRQ is -43.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -43.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-43.3%TTM-43.3%0.0%
TTM-43.3%YOY-32.3%-11.0%
TTM-43.3%5Y-24.7%-18.6%
5Y-24.7%10Y-24.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.3%-12.9%-30.4%
TTM-43.3%-12.3%-31.0%
YOY-32.3%-11.2%-21.1%
5Y-24.7%-13.5%-11.2%
10Y-24.7%-15.1%-9.6%
1.1.3. Return on Equity

Shows how efficient Achilles Therapeutics PLC ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • -49.1% Return on Equity means Achilles Therapeutics PLC ADR generated $-0.49 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Achilles Therapeutics PLC ADR:

  • The MRQ is -49.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -49.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.1%TTM-49.1%0.0%
TTM-49.1%YOY-36.1%-13.0%
TTM-49.1%5Y-27.5%-21.6%
5Y-27.5%10Y-27.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.1%-16.5%-32.6%
TTM-49.1%-15.7%-33.4%
YOY-36.1%-14.1%-22.0%
5Y-27.5%-18.8%-8.7%
10Y-27.5%-19.7%-7.8%

1.2. Operating Efficiency of Achilles Therapeutics PLC ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Achilles Therapeutics PLC ADR is operating .

  • Measures how much profit Achilles Therapeutics PLC ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--287.3%+287.3%
TTM--226.2%+226.2%
YOY--287.8%+287.8%
5Y--459.1%+459.1%
10Y--598.1%+598.1%
1.2.2. Operating Ratio

Measures how efficient Achilles Therapeutics PLC ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.246-3.246
TTM-3.303-3.303
YOY-3.753-3.753
5Y-5.557-5.557
10Y-7.396-7.396

1.3. Liquidity of Achilles Therapeutics PLC ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Achilles Therapeutics PLC ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.57 means the company has $8.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 8.569. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.569. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.569TTM8.5690.000
TTM8.569YOY10.925-2.357
TTM8.5695Y14.482-5.914
5Y14.48210Y14.4820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5693.821+4.748
TTM8.5694.161+4.408
YOY10.9255.313+5.612
5Y14.4826.113+8.369
10Y14.4826.474+8.008
1.3.2. Quick Ratio

Measures if Achilles Therapeutics PLC ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • A Quick Ratio of 8.35 means the company can pay off $8.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 8.348. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.348. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.348TTM8.3480.000
TTM8.348YOY10.523-2.175
TTM8.3485Y14.200-5.851
5Y14.20010Y14.2000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3483.474+4.874
TTM8.3483.993+4.355
YOY10.5235.388+5.135
5Y14.2006.105+8.095
10Y14.2006.442+7.758

1.4. Solvency of Achilles Therapeutics PLC ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Achilles Therapeutics PLC ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Achilles Therapeutics PLC ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Achilles Therapeutics PLC ADR assets are financed with 11.8% credit (debt) and the remaining percentage (100% - 11.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 0.118. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.118. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.118TTM0.1180.000
TTM0.118YOY0.106+0.012
TTM0.1185Y0.097+0.022
5Y0.09710Y0.0970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1180.347-0.229
TTM0.1180.340-0.222
YOY0.1060.272-0.166
5Y0.0970.368-0.271
10Y0.0970.388-0.291
1.4.2. Debt to Equity Ratio

Measures if Achilles Therapeutics PLC ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.4% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Achilles Therapeutics PLC ADR:

  • The MRQ is 0.134. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.134. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.134TTM0.1340.000
TTM0.134YOY0.118+0.016
TTM0.1345Y0.108+0.026
5Y0.10810Y0.1080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1340.395-0.261
TTM0.1340.411-0.277
YOY0.1180.339-0.221
5Y0.1080.438-0.330
10Y0.1080.469-0.361

2. Market Valuation of Achilles Therapeutics PLC ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Achilles Therapeutics PLC ADR generates.

  • Above 15 is considered overpriced but always compare Achilles Therapeutics PLC ADR to the Biotechnology industry mean.
  • A PE ratio of -0.53 means the investor is paying $-0.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Achilles Therapeutics PLC ADR:

  • The EOD is -0.477. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.527. Based on the earnings, the company is expensive. -2
  • The TTM is -0.527. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.477MRQ-0.527+0.051
MRQ-0.527TTM-0.5270.000
TTM-0.527YOY-0.525-0.003
TTM-0.5275Y-0.891+0.363
5Y-0.89110Y-0.8910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.477-2.437+1.960
MRQ-0.527-2.599+2.072
TTM-0.527-2.764+2.237
YOY-0.525-4.018+3.493
5Y-0.891-6.401+5.510
10Y-0.891-6.590+5.699
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Achilles Therapeutics PLC ADR:

  • The EOD is -0.670. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.742. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.742. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.670MRQ-0.742+0.071
MRQ-0.742TTM-0.7420.000
TTM-0.742YOY-0.557-0.185
TTM-0.7425Y-0.881+0.139
5Y-0.88110Y-0.8810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.670-3.111+2.441
MRQ-0.742-3.321+2.579
TTM-0.742-3.598+2.856
YOY-0.557-5.480+4.923
5Y-0.881-8.353+7.472
10Y-0.881-8.955+8.074
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Achilles Therapeutics PLC ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.26 means the investor is paying $0.26 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Achilles Therapeutics PLC ADR:

  • The EOD is 0.234. Based on the equity, the company is cheap. +2
  • The MRQ is 0.259. Based on the equity, the company is cheap. +2
  • The TTM is 0.259. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.234MRQ0.259-0.025
MRQ0.259TTM0.2590.000
TTM0.259YOY0.190+0.070
TTM0.2595Y0.233+0.026
5Y0.23310Y0.2330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2342.051-1.817
MRQ0.2592.143-1.884
TTM0.2592.120-1.861
YOY0.1902.878-2.688
5Y0.2333.601-3.368
10Y0.2333.972-3.739
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Achilles Therapeutics PLC ADR.

3.1. Institutions holding Achilles Therapeutics PLC ADR

Institutions are holding 50.887% of the shares of Achilles Therapeutics PLC ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Syncona Portfolio Ltd.27.18526.24811108690900
2023-12-31FCPM III SERVICES BV5.86040.6267239005023900500
2023-12-31Artal Group S A5.53020.0667225537500
2023-12-31Baker Bros Advisors LP5.15610.02132102792-454357-17.7681
2023-09-30Redmile Group, LLC3.9430.0696160808900
2023-09-30Point72 Asset Management, L.P.3.46670.0038141380900
2023-12-31Renaissance Technologies Corp1.22350.00074989956146714.0487
2023-12-31Vestal Point Capital LP0.2650.01021080831080830
2023-12-31Forefront Analytics, LLC0.1870.033576269-1900-2.4306
2023-09-30Citadel Advisors Llc0.1413057626-9217-13.789
2023-12-31Virtu Financial LLC0.09710.002839593395930
2023-12-31Millennium Management LLC0.07590309491467190.1278
2023-12-31Bank of America Corp0.0554022592-50650-69.1543
2023-12-31Geode Capital Management, LLC0.052902159000
2023-12-31TWO SIGMA SECURITIES, LLC0.03560.000114539145390
2023-12-31Global Retirement Partners, LLC.0.00740.0001300030000
2023-12-31JPMorgan Chase & Co0.0024098900
2023-12-31Qube Research & Technologies0.000207300
2023-12-31Royal Bank of Canada0.000103500
2023-12-31Morgan Stanley - Brokerage Accounts0020-50000-99.96
Total 53.28547.083621731377+2065279+9.5%

3.2. Funds holding Achilles Therapeutics PLC ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Forefront Tiresias Strategy0.16931.393170269-1900-2.6327
2024-02-29Fidelity Nasdaq Composite Index0.0520.00022159000
2024-03-31LUX IM Global Medtech HX0.04310.01031790000
Total 0.26441.4036109759-1900-1.7%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Achilles Therapeutics PLC ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.318-1.3180%-2.229+69%0.686-292%0.686-292%
Book Value Per Share--3.4313.4310%4.749-28%4.433-23%4.433-23%
Current Ratio--8.5698.5690%10.925-22%14.482-41%14.482-41%
Debt To Asset Ratio--0.1180.1180%0.106+12%0.097+22%0.097+22%
Debt To Equity Ratio--0.1340.1340%0.118+13%0.108+24%0.108+24%
Dividend Per Share----0%-0%-0%-0%
Eps---1.685-1.6850%-1.715+2%-1.202-29%-1.202-29%
Free Cash Flow Per Share---1.199-1.1990%-1.616+35%-1.137-5%-1.137-5%
Free Cash Flow To Equity Per Share---1.198-1.1980%-1.616+35%0.637-288%0.637-288%
Gross Profit Margin--1.1761.1760%1.000+18%1.035+14%1.035+14%
Intrinsic Value_10Y_max---17.142--------
Intrinsic Value_10Y_min---14.615--------
Intrinsic Value_1Y_max---1.531--------
Intrinsic Value_1Y_min---1.488--------
Intrinsic Value_3Y_max---4.743--------
Intrinsic Value_3Y_min---4.477--------
Intrinsic Value_5Y_max---8.126--------
Intrinsic Value_5Y_min---7.450--------
Market Cap33349933.350-11%36889499.50036889499.5000%37345950.000-1%56425580.900-35%56425580.900-35%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.234-11%0.2590.2590%0.190+37%0.233+11%0.233+11%
Pe Ratio-0.477+10%-0.527-0.5270%-0.525-1%-0.891+69%-0.891+69%
Price Per Share0.804-11%0.8890.8890%0.900-1%1.360-35%1.360-35%
Price To Free Cash Flow Ratio-0.670+10%-0.742-0.7420%-0.557-25%-0.881+19%-0.881+19%
Price To Total Gains Ratio-0.610+10%-0.675-0.6750%-0.404-40%0.332-303%0.332-303%
Quick Ratio--8.3488.3480%10.523-21%14.200-41%14.200-41%
Return On Assets---0.433-0.4330%-0.323-25%-0.247-43%-0.247-43%
Return On Equity---0.491-0.4910%-0.361-26%-0.275-44%-0.275-44%
Total Gains Per Share---1.318-1.3180%-2.229+69%0.686-292%0.686-292%
Usd Book Value--142369000.000142369000.0000%197044000.000-28%183932200.000-23%183932200.000-23%
Usd Book Value Change Per Share---1.318-1.3180%-2.229+69%0.686-292%0.686-292%
Usd Book Value Per Share--3.4313.4310%4.749-28%4.433-23%4.433-23%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.685-1.6850%-1.715+2%-1.202-29%-1.202-29%
Usd Free Cash Flow---49741054.000-49741054.0000%-67047000.000+35%-47177810.800-5%-47177810.800-5%
Usd Free Cash Flow Per Share---1.199-1.1990%-1.616+35%-1.137-5%-1.137-5%
Usd Free Cash Flow To Equity Per Share---1.198-1.1980%-1.616+35%0.637-288%0.637-288%
Usd Market Cap33349933.350-11%36889499.50036889499.5000%37345950.000-1%56425580.900-35%56425580.900-35%
Usd Price Per Share0.804-11%0.8890.8890%0.900-1%1.360-35%1.360-35%
Usd Profit---69935026.000-69935026.0000%-71176000.000+2%-49879805.200-29%-49879805.200-29%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.318-1.3180%-2.229+69%0.686-292%0.686-292%
 EOD+3 -5MRQTTM+0 -0YOY+16 -145Y+2 -2810Y+2 -28

4.2. Fundamental Score

Let's check the fundamental score of Achilles Therapeutics PLC ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.477
Price to Book Ratio (EOD)Between0-10.234
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.348
Current Ratio (MRQ)Greater than18.569
Debt to Asset Ratio (MRQ)Less than10.118
Debt to Equity Ratio (MRQ)Less than10.134
Return on Equity (MRQ)Greater than0.15-0.491
Return on Assets (MRQ)Greater than0.05-0.433
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Achilles Therapeutics PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.714
Ma 20Greater thanMa 500.799
Ma 50Greater thanMa 1001.064
Ma 100Greater thanMa 2000.993
OpenGreater thanClose0.800
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income Tax Expense  215-2123343774111-9,055-8,944



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets161,456
Total Liabilities19,087
Total Stockholder Equity142,369
 As reported
Total Liabilities 19,087
Total Stockholder Equity+ 142,369
Total Assets = 161,456

Assets

Total Assets161,456
Total Current Assets145,633
Long-term Assets15,823
Total Current Assets
Cash And Cash Equivalents 131,539
Net Receivables 10,351
Inventory 0
Other Current Assets 3,743
Total Current Assets  (as reported)145,633
Total Current Assets  (calculated)145,633
+/-0
Long-term Assets
Property Plant Equipment 13,543
Long-term Assets Other 2,206
Long-term Assets  (as reported)15,823
Long-term Assets  (calculated)15,749
+/- 74

Liabilities & Shareholders' Equity

Total Current Liabilities16,996
Long-term Liabilities2,091
Total Stockholder Equity142,369
Total Current Liabilities
Short-term Debt 3,539
Accounts payable 5,629
Other Current Liabilities 13,457
Total Current Liabilities  (as reported)16,996
Total Current Liabilities  (calculated)22,625
+/- 5,629
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,076
Long-term Liabilities Other 1,015
Long-term Liabilities  (as reported)2,091
Long-term Liabilities  (calculated)2,091
+/-0
Total Stockholder Equity
Common Stock182
Retained Earnings -259,952
Accumulated Other Comprehensive Income -13,071
Other Stockholders Equity 415,210
Total Stockholder Equity (as reported)142,369
Total Stockholder Equity (calculated)142,369
+/-0
Other
Capital Stock54
Cash and Short Term Investments 131,539
Common Stock Shares Outstanding 39,973
Current Deferred Revenue-5,629
Liabilities and Stockholders Equity 161,456
Net Debt -126,924
Net Invested Capital 142,369
Net Working Capital 128,637
Property Plant and Equipment Gross 26,458
Short Long Term Debt Total 4,615



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
0
105,205
218,918
317,106
220,358
161,456
161,456220,358317,106218,918105,2050
   > Total Current Assets 
13,376
103,061
187,797
284,749
196,580
145,633
145,633196,580284,749187,797103,06113,376
       Cash And Cash Equivalents 
0
97,594
177,849
266,319
173,338
131,539
131,539173,338266,319177,84997,5940
       Short-term Investments 
0
0
0
0
0
0
000000
       Net Receivables 
2,456
4,486
7,339
11,173
16,003
10,351
10,35116,00311,1737,3394,4862,456
       Other Current Assets 
237
477
851
2,124
2,615
3,743
3,7432,6152,124851477237
   > Long-term Assets 
0
2,144
31,121
32,357
23,778
15,823
15,82323,77832,35731,1212,1440
       Property Plant Equipment 
583
2,110
28,109
28,791
20,480
13,543
13,54320,48028,79128,1092,110583
       Other Assets 
0
0
3,012
3,566
3,298
0
03,2983,5663,01200
> Total Liabilities 
0
3,857
29,546
27,578
23,314
19,087
19,08723,31427,57829,5463,8570
   > Total Current Liabilities 
1,286
3,857
16,623
19,110
17,993
16,996
16,99617,99319,11016,6233,8571,286
       Short-term Debt 
0
487
3,712
4,482
4,188
3,539
3,5394,1884,4823,7124870
       Accounts payable 
129
902
6,314
3,722
5,187
5,629
5,6295,1873,7226,314902129
       Other Current Liabilities 
123
681
1,370
1,268
8,618
13,457
13,4578,6181,2681,370681123
   > Long-term Liabilities 
0
1,389
12,923
8,468
5,321
2,091
2,0915,3218,46812,9231,3890
       Other Liabilities 
0
0
652
691
933
0
093369165200
> Total Stockholder Equity
0
101,348
189,372
289,528
197,044
142,369
142,369197,044289,528189,372101,3480
   Common Stock
0
14
25
54
54
182
182545425140
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 
0
8,109
12,322
6,636
-21,695
-13,071
-13,071-21,6956,63612,3228,1090
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
-395
117,959
234,903
401,949
408,972
415,210
415,210408,972401,949234,903117,959-395



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4,731
Gross Profit-4,731-4,731
 
Operating Income (+$)
Gross Profit-4,731
Operating Expense-80,252
Operating Income-84,983-84,983
 
Operating Expense (+$)
Research Development67,908
Selling General Administrative17
Selling And Marketing Expenses12,327
Operating Expense80,25280,252
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-84,983
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-78,879-91,088
EBIT - interestExpense = -84,983
-78,879
-69,935
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-84,983-78,879
Earnings Before Interest and Taxes (EBITDA)-80,252
 
After tax Income (+$)
Income Before Tax-78,879
Tax Provision-27
Net Income From Continuing Ops-75,091-78,906
Net Income-69,935
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses84,983
Total Other Income/Expenses Net6,1050
 

Technical Analysis of Achilles Therapeutics PLC ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Achilles Therapeutics PLC ADR. The general trend of Achilles Therapeutics PLC ADR is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Achilles Therapeutics PLC ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Achilles Therapeutics PLC ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.8 < 0.85 < 0.875.

The bearish price targets are: 0.75 > 0.7402 > 0.74.

Tweet this
Achilles Therapeutics PLC ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Achilles Therapeutics PLC ADR. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Achilles Therapeutics PLC ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Achilles Therapeutics PLC ADR. The current macd is -0.07376519.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Achilles Therapeutics PLC ADR price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Achilles Therapeutics PLC ADR. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Achilles Therapeutics PLC ADR price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Achilles Therapeutics PLC ADR Daily Moving Average Convergence/Divergence (MACD) ChartAchilles Therapeutics PLC ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Achilles Therapeutics PLC ADR. The current adx is 33.53.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Achilles Therapeutics PLC ADR shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Achilles Therapeutics PLC ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Achilles Therapeutics PLC ADR. The current sar is 0.74.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Achilles Therapeutics PLC ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Achilles Therapeutics PLC ADR. The current rsi is 38.71. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Achilles Therapeutics PLC ADR Daily Relative Strength Index (RSI) ChartAchilles Therapeutics PLC ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Achilles Therapeutics PLC ADR. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Achilles Therapeutics PLC ADR price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Achilles Therapeutics PLC ADR Daily Stochastic Oscillator ChartAchilles Therapeutics PLC ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Achilles Therapeutics PLC ADR. The current cci is 30.69.

Achilles Therapeutics PLC ADR Daily Commodity Channel Index (CCI) ChartAchilles Therapeutics PLC ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Achilles Therapeutics PLC ADR. The current cmo is -11.45988534.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Achilles Therapeutics PLC ADR Daily Chande Momentum Oscillator (CMO) ChartAchilles Therapeutics PLC ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Achilles Therapeutics PLC ADR. The current willr is -41.55963303.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Achilles Therapeutics PLC ADR is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Achilles Therapeutics PLC ADR Daily Williams %R ChartAchilles Therapeutics PLC ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Achilles Therapeutics PLC ADR.

Achilles Therapeutics PLC ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Achilles Therapeutics PLC ADR. The current atr is 0.06468512.

Achilles Therapeutics PLC ADR Daily Average True Range (ATR) ChartAchilles Therapeutics PLC ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Achilles Therapeutics PLC ADR. The current obv is 18,619,225.

Achilles Therapeutics PLC ADR Daily On-Balance Volume (OBV) ChartAchilles Therapeutics PLC ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Achilles Therapeutics PLC ADR. The current mfi is 19.40.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Achilles Therapeutics PLC ADR Daily Money Flow Index (MFI) ChartAchilles Therapeutics PLC ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Achilles Therapeutics PLC ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Achilles Therapeutics PLC ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Achilles Therapeutics PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.714
Ma 20Greater thanMa 500.799
Ma 50Greater thanMa 1001.064
Ma 100Greater thanMa 2000.993
OpenGreater thanClose0.800
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Achilles Therapeutics PLC ADR with someone you think should read this too:
  • Are you bullish or bearish on Achilles Therapeutics PLC ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Achilles Therapeutics PLC ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Achilles Therapeutics PLC ADR

I send you an email if I find something interesting about Achilles Therapeutics PLC ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Achilles Therapeutics PLC ADR.

Receive notifications about Achilles Therapeutics PLC ADR in your mailbox!